Leaflet RELITAZ 10mg gastro-resistant tablets

Product code:
W66604003
Quantity:
28
Indicated for:
peptic ulcer; gastroesophageal reflux
Route of administration:
oral
Substance:
rabeprazole (proton pump inhibitor)
ATC
A02BC04 — Alimentary tract and metabolism | Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) | Proton pump inhibitors
Rabeprazole is a proton pump inhibitor used for the treatment of gastroesophageal reflux disease (GERD), gastric ulcers, and other conditions associated with excessive gastric acid secretion. It works by reducing gastric acid production, alleviating symptoms, and promoting healing of the gastric mucosa.

The medication is taken orally, as directed by a doctor, usually once daily before a meal. It is important for patients to follow the treatment regimen and inform the doctor about any other medications being used.

Patients should be aware of potential side effects, such as headaches, nausea, or diarrhea. It is important to inform the doctor of any unusual symptoms.

Common side effects include headaches, nausea, and diarrhea. In rare cases, severe reactions such as allergic reactions or hypomagnesemia may occur. Patients should be informed of these risks before use.

General data about RELITAZ 10mg

Substance:
rabeprazole
Date of latest medicines list:
01-06-2026
Product code:
W66604003
Concentration:
10mg
Pharmaceutical form:
gastro-resistant tablets
Quantity:
28
Product type:
Generic medicine
Price:
48.35 RON
Prescription status:
P-6L — Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.

Marketing authorisation

Manufacturer:
GAP S.A. - GRECIA
Holder:
DR. REDDY'S LABORATORIES ROMANIA SRL - ROMANIA
Number:
13031/2020/03
Shelf life:
2 years

Pharmaceutical forms available for rabeprazole

Concentrations available for rabeprazole

  • 10mg
  • 20mg